Product Information
- KRN23
Burosumab (KRN23), a human monoclonal antibody, treats CSHS and tumor-induced osteochondrosis by targeting FGF23.
Chemical properties
Technical inquiry about: TM-T77455 Burosumab
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.